PFE

PFIZER INC

Pharmaceutical Preparations · SIC 2834CIK 78003Held by 15 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

Revenue FY2025

$62.58B

Net Income FY2025

$7.77B

EPS (Basic, as reported)

$1.37

Net Margin FY2025

12.4%

ROE FY2025

9.0%

Total Equity

$86.48B

Shares Out

5.70B

Business description

PFIZER INC — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2007–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions

default rows · click any row to chart itRevenue: 52,824 → 62,579 +1.9% CAGR

Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025

Revenue52,82452,54653,64751,75041,90881,28891,79350,91463,62762,579

Cost of revenue(12,322)(11,228)(11,248)(10,219)(8,692)(30,821)(34,344)(24,954)(17,851)(16,067)

Selling, general & administrative(14,837)(14,784)(14,455)(14,350)(11,615)(12,703)(13,677)(14,771)(14,730)(13,794)

Interest expense(1,186)(1,270)(1,316)(1,574)(1,449)(1,291)(1,238)(2,209)(3,091)(2,671)

Interest & investment income47039133322673362511,624545603

Other income (expense), net(3,655)(1,315)(2,116)(3,578)(669)4,878(217)835(4,388)(6,724)

Pre-tax income8,35112,30511,88517,6827,49724,31134,7291,0588,0237,520

Income tax expense(1,123)(9,049)(706)(1,384)(477)(1,852)(3,328)(1,115)(28)(266)

Net income7,21521,30811,15316,2739,61621,97931,3722,1198,0317,771

EPS — basic$1.18$3.57$1.90$2.92$1.73$3.92$5.59$0.38$1.42$1.37

EPS — diluted$1.17$3.52$1.87$2.87$1.71$3.85$5.47$0.37$1.41$1.36

Shares outstanding — basic (M)6,0895,9705,8725,5695,5555,6015,6085,6435,6645,683

Shares outstanding — diluted (M)6,1596,0585,9775,6755,6325,7085,7335,7095,7005,713

Showing the latest 10 of 19 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.